VCM
OSIR

Venator Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Venator Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-218,300
Closed -$4.25M – 17
2015
Q2 		$4.25M Buy
218,300
+43,300
+25% +$766K 3.89% 12
2015
Q1 		$3.08M Buy
+175,000
New +$2.94M 2.99% 12

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Venator Capital Management's OSIR Position: Q3 2015 in Review

Venator Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2015, closing a stake of 218,300 shares — an estimated $4.25M sold.

Venator Capital Management first reported a position in OSIR in Q1 2015 and held it in 2 quarters. The position peaked at $4.25M in Q2 2015. 92 funds tracked by Wall St. Rank hold OSIR as of Q3 2015.

  • Venator Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Venator Capital Management sold 218,300 Osiris Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $4.25M.
  • Venator Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Venator Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $4.25M in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Venator Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.